KBIO COMPANY Inc. (KOSDAQ:038530)
South Korea · Delayed Price · Currency is KRW 269.00
+4.00 (1.51%)
At close: Jan 30, 2026
KBIO COMPANY Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '18 Dec 31, 2018 |
Operating Revenue | 83,849 | 76,514 | 27,325 | 31,129 | 8,722 | 5,708 |
Other Revenue | - | - | - | -0 | - | - |
| 83,849 | 76,514 | 27,325 | 31,129 | 8,722 | 5,708 | |
Revenue Growth (YoY) | 43.78% | 180.02% | -12.22% | 256.89% | 52.80% | 13.45% |
Cost of Revenue | 71,035 | 64,854 | 23,730 | 27,457 | 6,823 | 1,454 |
Gross Profit | 12,814 | 11,660 | 3,595 | 3,671 | 1,899 | 4,254 |
Selling, General & Admin | 8,406 | 8,257 | 3,695 | 3,001 | 5,986 | 4,720 |
Research & Development | 1,396 | 1,132 | - | - | - | - |
Amortization of Goodwill & Intangibles | 19.94 | 255.52 | 333.9 | 333.9 | 58.35 | - |
Other Operating Expenses | 227.44 | 273.27 | 65.02 | 80.58 | 150.43 | 38.94 |
Operating Expenses | 13,308 | 12,770 | 4,212 | 3,218 | 6,986 | 5,551 |
Operating Income | -494.22 | -1,110 | -616.78 | 453.41 | -5,087 | -1,297 |
Interest Expense | - | -78.02 | -60.82 | -1,207 | -1,781 | -1,336 |
Interest & Investment Income | 1,739 | 1,843 | 838.47 | 995.31 | 929.97 | 79.12 |
Earnings From Equity Investments | - | - | - | - | - | -515.95 |
Currency Exchange Gain (Loss) | 483.07 | 995.81 | 0.75 | -2.26 | -0.32 | -1.16 |
Other Non Operating Income (Expenses) | 177.75 | 198.19 | 16,366 | -1,457 | 58.91 | -53.08 |
EBT Excluding Unusual Items | 1,906 | 1,849 | 16,527 | -1,217 | -5,880 | -3,124 |
Gain (Loss) on Sale of Investments | -16,410 | -7,820 | -28,301 | -5,757 | -10,705 | 25.79 |
Gain (Loss) on Sale of Assets | 4.48 | 0.79 | -26.74 | 14.28 | - | 1,141 |
Asset Writedown | -3,902 | -3,890 | - | -54.46 | - | -2,730 |
Other Unusual Items | - | - | -17.45 | - | - | 215.41 |
Pretax Income | -18,402 | -9,861 | -11,817 | -7,015 | -16,585 | -4,472 |
Income Tax Expense | 320.22 | 132.3 | - | - | - | - |
Earnings From Continuing Operations | -18,722 | -9,993 | -11,817 | -7,015 | -16,585 | -4,472 |
Earnings From Discontinued Operations | - | - | -857.05 | -650.4 | -2,881 | - |
Net Income to Company | -18,722 | -9,993 | -12,674 | -7,665 | -19,466 | -4,472 |
Minority Interest in Earnings | 6,247 | 3,202 | - | - | - | 91.62 |
Net Income | -12,475 | -6,791 | -12,674 | -7,665 | -19,466 | -4,380 |
Net Income to Common | -12,475 | -6,791 | -12,674 | -7,665 | -19,466 | -4,380 |
Shares Outstanding (Basic) | 116 | 115 | 102 | 91 | 77 | 9 |
Shares Outstanding (Diluted) | 116 | 115 | 102 | 91 | 77 | 9 |
Shares Change (YoY) | 1.36% | 13.03% | 12.29% | 17.81% | 737.44% | 45.38% |
EPS (Basic) | -107.27 | -58.80 | -124.03 | -84.23 | -252.01 | -474.89 |
EPS (Diluted) | -107.46 | -59.00 | -124.39 | -84.23 | -252.30 | -475.00 |
Free Cash Flow | 5,860 | -190.34 | -1,471 | 3,768 | -1,213 | -10,880 |
Free Cash Flow Per Share | 50.39 | -1.65 | -14.40 | 41.41 | -15.70 | -1179.54 |
Gross Margin | 15.28% | 15.24% | 13.16% | 11.79% | 21.77% | 74.52% |
Operating Margin | -0.59% | -1.45% | -2.26% | 1.46% | -58.33% | -22.73% |
Profit Margin | -14.88% | -8.88% | -46.38% | -24.62% | -223.18% | -76.74% |
Free Cash Flow Margin | 6.99% | -0.25% | -5.38% | 12.11% | -13.91% | -190.60% |
EBITDA | 485.51 | -25.92 | -125.74 | 1,045 | -4,413 | -1,086 |
EBITDA Margin | 0.58% | -0.03% | -0.46% | 3.36% | -50.60% | -19.03% |
D&A For EBITDA | 979.73 | 1,084 | 491.03 | 591.58 | 674 | 211.03 |
EBIT | -494.22 | -1,110 | -616.78 | 453.41 | -5,087 | -1,297 |
EBIT Margin | -0.59% | -1.45% | -2.26% | 1.46% | -58.33% | -22.73% |
Advertising Expenses | - | 45.94 | 4 | 0.93 | 1,087 | 400.94 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.